336
Views
2
CrossRef citations to date
0
Altmetric
Drug Evaluation

Adagrasib: a novel inhibitor for KRASG12C-mutated non-small-cell lung cancer

ORCID Icon, , &
Pages 1037-1051 | Received 08 Nov 2022, Accepted 01 Mar 2023, Published online: 03 May 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (2)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.